{"commentary":{"count":36,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":21,"youtube":9,"podcast":6},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02364557\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"NCT02364557","nct_id":"NCT02364557","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct02364557. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":null,"arms":[{"description":"Standard of care systemic therapy at the discretion of the treating physician.","label":"Standard of Care (SOC)","type":"NO_INTERVENTION"},{"description":"Standard of care systemic therapy plus ablation of all metastases by stereotactic body radiotherapy or surgery at the discretion of the treating physician.","label":"Standard of Care + Ablation","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)"],"completion_date":{"date":"2025-09-04","type":"ACTUAL"},"conditions":["Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8","Metastatic Breast Carcinoma","Metastatic Malignant Neoplasm in the Bone","Metastatic Malignant Neoplasm in the Liver","Metastatic Malignant Neoplasm in the Lung","Metastatic Malignant Neoplasm in the Lymph Nodes","Metastatic Malignant Neoplasm in the Spine","Prognostic Stage IV Breast Cancer AJCC v8","Anatomic Stage IV Breast Cancer AJCC v8"],"enrollment":{"count":129,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"Stereotactic Body Radiotherapy","type":"RADIATION"},{"name":"Surgery","type":"PROCEDURE"}],"last_update":"2026-07-10","lead_sponsor":"NRG Oncology","official_title":"A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer","overall_status":"COMPLETED","phases":["PHASE2","PHASE3"],"primary_completion_date":{"date":"2021-12-20","type":"ACTUAL"},"primary_outcomes":[{"measure":"Progression-free Survival (Phase II)","timeFrame":"From randomization to last follow-up. Follow-up schedule: 3 mos after randomization and every 3 months to 24 months, then every six months to five years, then annually. Maximum follow-up at time of analysis was 63 months."},{"measure":"Overall Survival (Phase III)","timeFrame":"From randomization to last follow-up. Follow-up schedule: 3 mos after randomization and every 3 months to 24 months and then annually. Maximum follow-up at time of analysis was 63 months."}],"references":[{"citation":"Petrelli F, Ghidini A, Ghidini M, Bukovec R, Trevisan F, Turati L, Indini A, Seghezzi S, Lonati V, Moleri G, Tomasello G, Zaniboni A. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Res. 2021 May 27;10:423. doi: 10.12688/f1000research.52546.4. eCollection 2021.","pmid":"35602670","type":"DERIVED"}],"start_date":{"date":"2014-12-24","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival","url":"https://clinicaltrials.gov/study/NCT02364557"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct02364557"}